These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 12448968)
1. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis]. Peeters KA; Mascini EM; Blok HE; Sanders CJ Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968 [TBL] [Abstract][Full Text] [Related]
2. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis]. Koning S; Thomas S; van der Wouden JC Ned Tijdschr Geneeskd; 2003 Jan; 147(3):134; author reply 135. PubMed ID: 12577775 [No Abstract] [Full Text] [Related]
3. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use. Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448 [TBL] [Abstract][Full Text] [Related]
5. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use. Mitra A; Mohanraj M; Shah M Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization. Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934 [TBL] [Abstract][Full Text] [Related]
7. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole]. Memikoğlu KO; Bayar B; Kurt O; Cokça F Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections. Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960 [TBL] [Abstract][Full Text] [Related]
10. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Howden BP; Grayson ML Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088 [TBL] [Abstract][Full Text] [Related]
11. Resistance of Staphylococcus aureus to fusidic acid. Peeters KA; Mascini EM; Sanders CJ Int J Dermatol; 2004 Mar; 43(3):235-6. PubMed ID: 15009402 [No Abstract] [Full Text] [Related]
12. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci. Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340 [TBL] [Abstract][Full Text] [Related]
13. Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients. Edslev SM; Clausen ML; Agner T; Stegger M; Andersen PS J Antimicrob Chemother; 2018 Apr; 73(4):856-861. PubMed ID: 29253168 [TBL] [Abstract][Full Text] [Related]
14. [Nasal carriage of Staphylococcus aureus in hospital personnel and the normal population and antibiotic resistance of the isolates]. Yazgi H; Ertek M; Ozbek A; Kadanali A Mikrobiyol Bul; 2003; 37(2-3):137-42. PubMed ID: 14593895 [TBL] [Abstract][Full Text] [Related]
15. Effect of withdrawing topical fusidic acid on Staphylococcus aureus resistance rates. Wylie G; Dancer SJ; Bilsland D Scott Med J; 2011 Feb; 56(1):10-1. PubMed ID: 21515524 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis. McLaws F; Chopra I; O'Neill AJ J Antimicrob Chemother; 2008 May; 61(5):1040-3. PubMed ID: 18299637 [TBL] [Abstract][Full Text] [Related]
17. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries. den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521 [TBL] [Abstract][Full Text] [Related]
18. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco). Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537 [TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. Norazah A; Lim VK; Rohani MY; Kamel AG Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701 [TBL] [Abstract][Full Text] [Related]
20. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area. El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]